Dr Chris Barbosa

Christopher J. Barbosa, Vice President of Technology Development at Acuitas Therapeutics, leads the internal development of the company’s core lipid technology and associated clinical drug product manufacturing technologies. He also oversees the transfer of these technologies to enable Acuitas’ partners to reach the clinic and commercialisation as safely, effectively and rapidly as possible. Chris obtained his PhD in Chemistry and Biotechnology from the University of British Columbia and has held leadership roles in novel drug delivery system R&D at INEX Pharmaceuticals and Angiotech Pharmaceuticals.